March 2024
1. SMAGRIS E, Shihanian LM, Mintah IJ, Bigdelou P, et al
   Divergent role of Mitochondrial Amidoxime Reducing Component 1 (MARC1) in human and mouse.
   PLoS Genet. 2024;20:e1011179.
   

   >> Share

   
   
2. MA RK, Tsai PY, Farghli AR, Shumway A, et al
   DNAJB1-PRKACA fusion protein-regulated LINC00473 promotes tumor growth and alters mitochondrial fitness in fibrolamellar carcinoma.
   PLoS Genet. 2024;20:e1011216.
   

   >> Share

   
   December 2023
3. HUANG P, Duan W, Ruan C, Wang L, et al
   NeuroD1-GPX4 signaling leads to ferroptosis resistance in hepatocellular carcinoma.
   PLoS Genet. 2023;19:e1011098.
   

   >> Share

   
   January 2023
4. WATTACHERIL JJ, Raj S, Knowles DA, Greally JM, et al
   Using epigenomics to understand cellular responses to environmental influences in diseases.
   PLoS Genet. 2023;19:e1010567.
   

   >> Share

   
   August 2022
5. KIYOSE H, Nakagawa H, Ono A, Aikata H, et al
   Comprehensive analysis of full-length transcripts reveals novel splicing abnormalities and oncogenic transcripts in liver cancer.
   PLoS Genet. 2022;18:e1010342.
   

   >> Share

   
   December 2021
6. ZHANG W, Wu C, Ni R, Yang Q, et al
   Formimidoyltransferase cyclodeaminase prevents the starvation-induced liver hepatomegaly and dysfunction through downregulating mTORC1.
   PLoS Genet. 2021;17:e1009980.
   

   >> Share

   
   June 2021
7. KESHVARI S, Caruso M, Teakle N, Batoon L, et al
   CSF1R-dependent macrophages control postnatal somatic growth and organ maturation.
   PLoS Genet. 2021;17:e1009605.
   

   >> Share

   
   
8. CRAIG AJ, Garcia-Lezana T, Ruiz de Galarreta M, Villacorta-Martin C, et al
   Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinoma.
   PLoS Genet. 2021;17:e1009589.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share